Lifecore Biomedical (LFCR) News Today $7.86 +0.18 (+2.34%) Closing price 04:00 PM EasternExtended Trading$7.86 0.00 (-0.06%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LFCR Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Lifecore Biomedical (LFCR) Soars 10.8%: Is Further Upside Left in the Stock?September 12, 2025 | msn.comLifecore Biomedical (LFCR) Initiated with a Hold at KeyBancSeptember 10, 2025 | theglobeandmail.comLifecore Biomedical, Inc. (LFCR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeptember 9, 2025 | seekingalpha.comWhat is KeyCorp's Estimate for LFCR Q1 Earnings?September 7, 2025 | marketbeat.comAnalysts Offer Predictions for LFCR Q1 EarningsSeptember 7, 2025 | americanbankingnews.comLifecore Biomedical (NASDAQ:LFCR) Raised to "Hold" at KeyCorpSeptember 6, 2025 | marketbeat.comKeyCorp Begins Coverage on Lifecore Biomedical (NASDAQ:LFCR)September 5, 2025 | americanbankingnews.comLifecore granted Sector Weight rating at KeyBanc on growth trajectorySeptember 4, 2025 | msn.comKeybanc Initiates Coverage of Lifecore Biomedical (LFCR) with Sector Weight RecommendationSeptember 4, 2025 | msn.comLifecore Biomedical, Inc. to Sponsor and Exhibit at 24th Annual Contract Pharma ConferenceSeptember 4, 2025 | quiverquant.comQLifecore Biomedical to Participate at 24th Annual Contract Pharma Contracting and Outsourcing ConferenceSeptember 4, 2025 | globenewswire.comLifecore Biomedical to Participate in Upcoming Investor ConferencesSeptember 2, 2025 | globenewswire.comLifecore Biomedical, Inc.'s (NASDAQ:LFCR) Intrinsic Value Is Potentially 44% Above Its Share PriceSeptember 1, 2025 | finance.yahoo.comAlpha Wave Global LP Reduces Holdings in Lifecore Biomedical, Inc. $LFCRAugust 28, 2025 | marketbeat.comBoston Partners Invests $241,000 in Lifecore Biomedical, Inc. $LFCRAugust 21, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Lifecore Biomedical (LFCR) and ADMA Biologics (ADMA)August 20, 2025 | theglobeandmail.comLifecore Biomedical (LFCR) to Release Quarterly Earnings on MondayAugust 19, 2025 | marketbeat.comLifecore Biomedical (NASDAQ:LFCR) Upgraded to Hold at Wall Street ZenAugust 17, 2025 | marketbeat.comLIFECORE ALERT: Bragar Eagel & Squire, P.C. is Investigating LifeCore Biomedical, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmAugust 14, 2025 | globenewswire.comCraig-Hallum Sticks to Its Buy Rating for Lifecore Biomedical (LFCR)August 12, 2025 | theglobeandmail.comLifecore Biomedical Full Year 2025 Earnings: EPS Beats ExpectationsAugust 11, 2025 | finance.yahoo.comLifecore Biomedical, Inc. (LFCR) Q4 2025 Earnings Call TranscriptAugust 8, 2025 | seekingalpha.comLifecore Biomedical Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides Corporate UpdateAugust 7, 2025 | globenewswire.comDCF Advisers LLC Sells 56,989 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR)August 4, 2025 | marketbeat.comLifecore Biomedical, Inc. to Report Q4 and Fiscal Year 2025 Financial Results on August 7, 2025July 31, 2025 | quiverquant.comQLifecore Biomedical to Report Fourth Quarter and Fiscal Year 2025 Financial Results on August 7, 2025July 31, 2025 | globenewswire.comLaughing Water Capital’s View on Lifecore Biomedical (LFCR)July 24, 2025 | finance.yahoo.comLaughing Water Capital’s View on Lifecore Biomedical Inc. (LFCR)July 24, 2025 | insidermonkey.comLifecore Biomedical (NASDAQ:LFCR) Trading Down 2.5% - What's Next?July 19, 2025 | marketbeat.comLifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)July 17, 2025 | globenewswire.comLifecore Biomedical Insider Ups Holding During YearJuly 7, 2025 | finance.yahoo.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Position Trimmed by Rhumbline AdvisersJune 26, 2025 | marketbeat.comLifecore Biomedical: Inflecting Financials Over Next 3 YearsJune 18, 2025 | seekingalpha.comLifecore Biomedical signs new 10-year commercial manufacturing and supply agreementJune 17, 2025 | msn.comLifecore Biomedical Signs New 10-Year Commercial Manufacturing and Supply Agreement with Key Existing CustomerJune 17, 2025 | globenewswire.comLifecore Receives Full Payment Early For $17 Mln Equipment SaleJune 14, 2025 | nasdaq.comLifecore Biomedical, Inc.: Lifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment SaleJune 12, 2025 | finanznachrichten.deLifecore Biomedical receives accelerated payment of remaining $10M in proceeds from equipment saleJune 12, 2025 | msn.comLifecore Biomedical Receives Accelerated Payment of Remaining $10 Million in Proceeds from Prior Equipment SaleJune 12, 2025 | globenewswire.comDeutsche Bank AG Reduces Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR)June 3, 2025 | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Sold by BNP Paribas Financial MarketsJune 1, 2025 | marketbeat.comInsider Selling: Lifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Sells 96,137 Shares of StockMay 30, 2025 | marketbeat.comAron R. English Sells 150,419 Shares of Lifecore Biomedical, Inc. (NASDAQ:LFCR) StockMay 30, 2025 | marketbeat.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Aron R. English Sells 1,139,504 SharesMay 30, 2025 | marketbeat.comLifecore Biomedical (NASDAQ:LFCR) shareholders have endured a 37% loss from investing in the stock five years agoMay 29, 2025 | finance.yahoo.comLifecore Biomedical, Inc. (NASDAQ:LFCR) Major Shareholder Aron R. English Sells 96,137 SharesMay 29, 2025 | insidertrades.comLifecore Biomedical Names Mark DaFonseca Chief Commercial OfficerMay 27, 2025 | globenewswire.comQ4 Earnings Estimate for LFCR Issued By William BlairMay 25, 2025 | marketbeat.comWilliam Blair Initiates Coverage on Lifecore Biomedical (NASDAQ:LFCR)May 23, 2025 | marketbeat.comLifecore stock gains on Outperform rating by William BlairMay 22, 2025 | investing.com Get Lifecore Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for LFCR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFCR Media Mentions By Week LFCR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LFCR News Sentiment▼0.820.92▲Average Medical News Sentiment LFCR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LFCR Articles This Week▼43▲LFCR Articles Average Week Get the Latest News and Ratings for LFCR and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Lifecore Biomedical and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ARS Pharmaceuticals News Today Dianthus Therapeutics News Today Oric Pharmaceuticals News Today Upstream Bio News Today Spyre Therapeutics News Today Pharming Group News Today Urogen Pharma News Today CorMedix News Today atai Life Sciences News Today uniQure News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LFCR) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lifecore Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lifecore Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LFCR Stock Alerts